These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 29485185)

  • 1. Hypoxia and acidosis: immune suppressors and therapeutic targets.
    Damgaci S; Ibrahim-Hashim A; Enriquez-Navas PM; Pilon-Thomas S; Guvenis A; Gillies RJ
    Immunology; 2018 Jul; 154(3):354-362. PubMed ID: 29485185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
    Noman MZ; Hasmim M; Messai Y; Terry S; Kieda C; Janji B; Chouaib S
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C569-79. PubMed ID: 26310815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
    Chouaib S
    Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cell promotion of metastasis.
    Kitamura T; Qian BZ; Pollard JW
    Nat Rev Immunol; 2015 Feb; 15(2):73-86. PubMed ID: 25614318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: From mechanisms to therapy.
    Meybodi SM; Ejlalidiz M; Manshadi MR; Raeisi M; Zarin M; Kalhor Z; Saberiyan M; Hamblin MR
    Crit Rev Oncol Hematol; 2024 May; 197():104340. PubMed ID: 38570176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
    Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
    Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypoxic tumour microenvironment: A safe haven for immunosuppressive cells and a therapeutic barrier to overcome.
    Chang WH; Lai AG
    Cancer Lett; 2020 Sep; 487():34-44. PubMed ID: 32470490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Regulation and Antitumor Effect of TIM-1.
    Du P; Xiong R; Li X; Jiang J
    J Immunol Res; 2016; 2016():8605134. PubMed ID: 27413764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?
    Vahidian F; Duijf PHG; Safarzadeh E; Derakhshani A; Baghbanzadeh A; Baradaran B
    Immunol Lett; 2019 Apr; 208():19-29. PubMed ID: 30862442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
    Mooradian MJ; Sullivan RJ
    Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?
    Abou Khouzam R; Zaarour RF; Brodaczewska K; Azakir B; Venkatesh GH; Thiery J; Terry S; Chouaib S
    Front Immunol; 2022; 13():828875. PubMed ID: 35211123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy.
    Xie G; Cheng T; Lin J; Zhang L; Zheng J; Liu Y; Xie G; Wang B; Yuan Y
    J Immunother Cancer; 2018 Sep; 6(1):88. PubMed ID: 30208943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response.
    Noman MZ; Messai Y; Carré T; Akalay I; Méron M; Janji B; Hasmim M; Chouaib S
    Crit Rev Immunol; 2011; 31(5):357-77. PubMed ID: 22142164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quiescence as a mechanism for cyclical hypoxia and acidosis.
    Smallbone K; Gavaghan DJ; Maini PK; Brady JM
    J Math Biol; 2007 Nov; 55(5-6):767-79. PubMed ID: 17609956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour acidosis: from the passenger to the driver's seat.
    Corbet C; Feron O
    Nat Rev Cancer; 2017 Oct; 17(10):577-593. PubMed ID: 28912578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic changes and interaction of tumor cell, myeloid-derived suppressor cell and T cell in hypoxic microenvironment.
    Ou X; Lv W
    Future Oncol; 2020 Mar; 16(8):383-393. PubMed ID: 32067476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuning cancer fate: the unremitting role of host immunity.
    Calì B; Molon B; Viola A
    Open Biol; 2017 Apr; 7(4):. PubMed ID: 28404796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
    Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.